I TO I
Dead / Abandoned — Abandoned — no statement of use filed (as of 30 Jun 2025)
What this means for you
This application is over — abandoned 30 Jun 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97657739
- Mark type
- Stylized text
- Filed
- 01 Nov 2022
- Published for opposition
- 30 Jan 2024
- Abandoned
- 30 Jun 2025
- Attorney of record
- Eric Lamb
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic preparations for medical purposes; Drug delivery agents in the form of powders, tablets, capsules, solutions, cells and nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Tumor suppressing agents; Pharmaceutical products for the prevention and treatment of cancer; Medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biological preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biochemical medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor
Owner
- Nona Biosciences US, Inc., Natick, MA, US
- Nona Biosciences US, Inc., Natick, MA, US
Prosecution history
- 30 Jun 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 30 Jun 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 28 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2025 — CORRECTED NOA E-MAILED
- 27 Jun 2025 — SOU EXTENSION 1 GRANTED
- 23 Sept 2024 — SOU EXTENSION 1 FILED
- 27 Jun 2025 — DIVISIONAL PROCESSING COMPLETE
- 24 Sept 2024 — DIVISIONAL REQUEST RECEIVED
- 26 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Sept 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 24 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 26 Mar 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jan 2024 — PUBLISHED FOR OPPOSITION